Orthofix Reports Fourth Quarter and Fiscal Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Orthofix International (OFIX) Tops Q4 EPS by 25c, Revenues Beat; Offers FY21 EPS/Revenue Outlook
February 26, 2021 7:04 AM ESTOrthofix International (NASDAQ: OFIX) reported Q4 EPS of $0.44, $0.25 better than the analyst estimate of $0.19. Revenue for the quarter came in at $117.6 million versus the consensus estimate of $113.2 million.
Fourth quarter net sales of $117.6 million, within 3% of our 2019 resultsUS Spine implant sales grew 11% compared to fourth quarter 2019, driven by record M6-C artificial cervical disc performanceStrong cash flow performance in the quarter, free cash flow of $17.9 millionFITBONE® intramedullary lengthening and deformity system receives FDA clearance for pediatric indicationWe were very pleased with our performance during... More
